CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-08 | Pacelli Steven Robert EVP Managing Director Dexcom V | Grant or award | +18,776 | $0.00 | $19 | 155,240 |
| 2023-03-08 | Selvaraj Shelly Ramasamy SVP Chief Information Officer | Grant or award | +10,885 | $0.00 | $11 | 60,984 |
| 2023-03-08 | Stern Sadie EVP Chief Human Resources Offi | Grant or award | +21,769 | $0.00 | $22 | 90,153 |
| 2023-03-08 | Sylvain Jereme M EVP Chief Financial Officer | Grant or award | +21,769 | $0.00 | $22 | 86,729 |
| 2023-03-06 | Leach Jacob Steven EVP Chief Technology Officer | Sale | −10,425 | $114.45 | $1.2M | 288,808 |
| 2023-03-06 | Leach Jacob Steven EVP Chief Technology Officer | Sale | −7,719 | $115.13 | $889K | 281,089 |
| 2023-03-06 | Dolan Matthew Vincent SVP Corporate Strategy-Develop | Sale | −226 | $114.40 | $26K | 26,536 |
| 2023-03-01 | SAYER KEVIN R President CEO and Chairman of | Sale | −31,203 | $109.83 | $3.4M | 338,598 |
| 2023-03-01 | SAYER KEVIN R President CEO and Chairman of | Sale | −7,261 | $110.41 | $802K | 331,337 |
| 2023-02-23 | Pacelli Steven Robert EVP Managing Director Dexcom V | Sale | −412 | $111.64 | $46K | 136,464 |
| 2023-02-22 | Sylvain Jereme M EVP Chief Financial Officer | Sale | −2,400 | $114.54 | $275K | 64,837 |
| 2023-01-30 | Regan Barry J. EVP Operations | Sale | −2,213 | $106.12 | $235K | 59,386 |
| 2023-01-30 | SAYER KEVIN R President CEO and Chairman of | Sale | −47,693 | $106.06 | $5.1M | 378,952 |
| 2023-01-30 | SAYER KEVIN R President CEO and Chairman of | Sale | −9,151 | $106.65 | $976K | 369,801 |
| 2023-01-23 | Pacelli Steven Robert EVP Managing Director Dexcom V | Sale | −412 | $107.86 | $44K | 136,876 |
| 2023-01-20 | SAYER KEVIN R President CEO and Chairman of | Sale | −45,607 | $105.75 | $4.8M | 426,645 |
| 2023-01-18 | SAYER KEVIN R President CEO and Chairman of | Grant or award | +90,720 | 472,252 | ||
| 2022-12-23 | Pacelli Steven Robert EVP Managing Director Dexcom V | Sale | −412 | $112.57 | $46K | 137,288 |
| 2022-12-08 | Flynn Paul R EVP Global Revenue | Sale | −8,988 | $123.50 | $1.1M | 55,744 |
| 2022-11-21 | Sylvain Jereme M EVP Chief Financial Officer | Sale | −2,400 | $112.62 | $270K | 67,237 |
Page 20 of 40 · 785 trades